Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEMBROLIZUMAB Cause Product preparation issue? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Product preparation issue have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.

12
Reports of Product preparation issue with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product preparation issue From PEMBROLIZUMAB?

Of the 12 reports, 1 (8.3%) required hospitalization.

Is Product preparation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does PEMBROLIZUMAB Cause?

Malignant neoplasm progression (10,111) Death (4,744) Diarrhoea (4,251) Fatigue (3,833) Off label use (3,416) Product use in unapproved indication (3,191) Pyrexia (3,155) Rash (2,900) Nausea (2,670) Decreased appetite (2,486)

What Other Drugs Cause Product preparation issue?

ONABOTULINUMTOXINA (677) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (252) HUMAN C1-ESTERASE INHIBITOR (238) SOMATROPIN (200) INCOBOTULINUMTOXINA (174) STIRIPENTOL (129) TESAMORELIN (119) ABATACEPT (115) INFLIXIMAB (101) ABOBOTULINUMTOXINA (91)

Which PEMBROLIZUMAB Alternatives Have Lower Product preparation issue Risk?

PEMBROLIZUMAB vs PEMETREXED PEMBROLIZUMAB vs PEMIGATINIB PEMBROLIZUMAB vs PENICILLAMINE PEMBROLIZUMAB vs PENICILLIN PEMBROLIZUMAB vs PENICILLIN G

Related Pages

PEMBROLIZUMAB Full Profile All Product preparation issue Reports All Drugs Causing Product preparation issue PEMBROLIZUMAB Demographics